1) Derynck R,Miyazono K:The TGF-β Family,Cold Spring Harbor Laboratory Press,Cold Spring Harbor,2008.
3) Ikushima H,Miyazono K:TGF-β signaling transduction spreading to a wider field:abroad variety of mechanisms for context-dependent effects of TGF-β.Cell Tissue Res 347:37-49,2012.
5) Heldin CH,et al:Mechanism of TGF-β signaling to growth arrest,apoptosis,and epithelial-mesenchymal transition.Curr Opin Cell Biol 21:166-176,2009.
6) Xu J,et al:TGF-β-induced epithelial to mesenchymal transition.Cell Res 19:156-172,2009.
7) Gorelik L,Flavell RA:Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells.Nat Med 7:1118-1122,2001.
8) Ghiringhelli F,et al:CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-β-dependent manner.J Exp Med 202:1075-1085,2005.
9) Komuro A,et al:Diffuse-type gastric carcinoma:progression,angiogenesis, and transforming growth factor β signaling.J Natl Cancer Inst 101:592-604,2009.
10) Ikushima H,Miyazono K:TGF-β signaling:a complex web in cancer progression.Nature Rev Cancer 10:413-424, 2010.
11) Tang B,et al:Transforming growth factor-β can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cell and committed progeny in a breast cancer xenograft model.Cancer Res 67:8643-8652,2007.
12) Penuelas S,et al:TGF-β increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma.Cancer Cell 15:315-327,2009.
13) Naka K,et al:TGF-β-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia.Nature 463:676-680,2010.
14) Pohlers D,et al:TGF-β and fibrosis in different organs-molecular pathway imprints. Biochim Biophys Acta 1792:746-756,2009.
15) Hawinkels LJ,Ten Dijke P:Exploring anti-TGF-β therapies in cancer and fibrosis.Growth Factors 29:140-152,2011.
16) Meulmeester E,Ten Dijke P:The dynamic role of TGF-β in cancer.J Pathol 223:205-218,2011.